Abstract
Recent evidence suggests that mesenchymal stem cells (MSC) selectively home to tumors, where they contribute to the formation of tumor-associated stroma. This effect can be opposed by genetically modifying MSC to produce high levels of anticancer agents that blunt tumor growth kinetics and inhibit the growth of tumors in situ. In this review article, we describe the biological properties of MSC within the tumor microenvironment and discuss the potential use of MSC and other bone marrow-derived cell populations as delivery vehicles for antitumor proteins.
Original language | English (US) |
---|---|
Pages (from-to) | 8-16 |
Number of pages | 9 |
Journal | International journal of hematology |
Volume | 86 |
Issue number | 1 |
DOIs | |
State | Published - Jul 2007 |
Keywords
- Gene therapy
- Mesenchymal stem cells
- Stroma
- Tumor microenvironment
- Vascular network
ASJC Scopus subject areas
- Hematology